Neurosense Therapeutics Ltd
NRSN1.049USD
+0.009+0.84%
收盤 11/05, 16:00（美東）報價延遲15分鐘
25.80M總市值
虧損本益比TTM
關於 Neurosense Therapeutics Ltd 公司
NeuroSense Therapeutics Ltd 是一家位於以色列的臨牀階段製藥公司。該公司活躍於藥物開發和治療領域，爲肌萎縮側索硬化症 (ALS) 患者以及其他神經退行性疾病提供藥物。該公司的主要候選產品 PrimeC 是一種由特定比例的藥物組成的固定劑量組合口服制劑。除了 PrimeC 之外，該公司還啓動了阿爾茨海默病和帕金森病的研究和開發工作
Neurosense Therapeutics Ltd簡介
公司代碼NRSN
公司名稱Neurosense Therapeutics Ltd
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
員工數量15
證券類型Ordinary Share
年結日Dec 09
公司地址11 Hamenofim St.
城市HERZLIYA
上市交易所NASDAQ Capital Market Consolidated
國家Israel
郵編4672562
電話97299531142
網址https://www.neurosense-tx.com/
公司代碼NRSN
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
Neurosense Therapeutics Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 3 小時前
更新時間: 3 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Ben-Noon (Alon)
12.68%
Rimon Gold Assets Ltd
9.20%
Eisenberg (Or)
1.92%
Tracik (Ferenc)
0.76%
Citadel Advisors LLC
0.60%
其他
74.85%
持股股東
持股股東
佔比
Ben-Noon (Alon)
12.68%
Rimon Gold Assets Ltd
9.20%
Eisenberg (Or)
1.92%
Tracik (Ferenc)
0.76%
Citadel Advisors LLC
0.60%
其他
74.85%
股東類型
持股股東
佔比
Individual Investor
16.35%
Corporation
9.20%
Hedge Fund
0.60%
Research Firm
0.52%
Investment Advisor
0.36%
Investment Advisor/Hedge Fund
0.31%
其他
72.66%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
29
440.13K
1.76%
-1.60M
2025Q2
37
7.64M
31.03%
+143.76K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
2023Q2
33
6.46M
53.11%
+1.06M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Ben-Noon (Alon)
3.18M
12.68%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
9.2%
+2.30M
--
Dec 02, 2024
Eisenberg (Or)
480.92K
1.92%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.76%
+66.67K
+54.22%
Apr 07, 2025
Citadel Advisors LLC
149.24K
0.6%
+149.24K
--
Jun 30, 2025
Morgan Stanley & Co. LLC
79.90K
0.32%
+29.40K
+58.21%
Jun 30, 2025
Russek-Blum (Niva)
75.43K
0.3%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.26%
--
--
Apr 07, 2025
Squarepoint Capital LLP
49.92K
0.2%
+49.92K
--
Jun 30, 2025
Meitav Dash Investments Ltd.
40.00K
0.16%
--
--
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
